Almost 50% of the males older than 60 years and approximately 80% of those over the age of 80 suffer from benign prostatic hyperplasia, a benign growth of this gland that compresses the urethra and cause problems at the time of urination, bladder stones and even kidney failure.
Prostatic photovaporisation with green light KTP laser is a new minimally invasive technique used as alternative to transurethral resection surgery of prostate cancer, the most common treatment for treating benign prostatic hyperplasia. It consists in vaporising the prostate tissue that compresses the urine tract, so that the patient can regain their ability to void normally.
It is a safe technique, which does not produce bleeding and delivers results as effective as those obtained after the surgery, with the advantages that the patient remains less than 24h and can resume normal life within 2 or 3 days. In addition, there is an immediate relief of symptoms and the results are sustained over the longer term.
